|
|
肠道微生物与慢性疾病
|
Abstract:
近年来，随着世界经济的快速发展，人们的生活品质也不断提升，慢性疾病已经开始严重危害人们的健康。而糖尿病，动脉粥样化，高血压，心力衰竭等疾病的发病率的逐渐升高也成为了一个严重的问题，为此，国家也在不断为提升慢性病的治疗率降低慢性病的死亡率而努力。随着对慢性疾病研究的深入，很多研究都表明肠道微生物在慢性疾病的发生中有很重要的作用。
In recent years, with the rapid development of the world economy, people’s quality of life has been continuously improving, and chronic diseases have begun to seriously endanger people’s health. The increasing incidence of diseases such as diabetes, atherosclerosis, hypertension, and heart failure has become a serious problem. Therefore, the country is constantly striving to improve the treatment rate of chronic diseases and reduce the mortality rate. With in-depth research on chronic diseases, many studies have shown that gut microbiota plays an important role in the occurrence of chronic diseases.
| [1] | Tang, W.H.W., Li, D.Y. and Hazen, S.L. (2018) Dietary Metabolism, the Gut Microbiome, and Heart Failure. Nature Reviews Cardiology, 16, 137-154. https://doi.org/10.1038/s41569-018-0108-7 |
| [2] | 刘月姣. 《中国居民营养与慢性病状况报告(2020年)》发布[J]. 中国食物与营养, 2020, 26(12): 2. |
| [3] | 谢果珍, 黄莉莉, 张水寒, 等. 肠道微生物代谢苷类化合物的研究进展[J]. 天然产物研究与开发, 2022, 34(7): 1261-1271. |
| [4] | 毕玉晶, 杨瑞馥. 人体肠道微生物群、营养与健康[J]. 科学通报, 2019, 64(3): 260-271. |
| [5] | Oussaada, S.M., van Galen, K.A., Cooiman, M.I., Kleinendorst, L., Hazebroek, E.J., van Haelst, M.M., et al. (2019) The Pathogenesis of Obesity. Metabolism, 92, 26-36. https://doi.org/10.1016/j.metabol.2018.12.012 |
| [6] | La Sala, M.S., Hurtado, M.D., Brown, A.R., Bohórquez, D.V., Liddle, R.A., Herzog, H., et al. (2013) Modulation of Taste Responsiveness by the Satiation Hormone Peptide YY. The FASEB Journal, 27, 5022-5033. https://doi.org/10.1096/fj.13-228064 |
| [7] | Swartz, T.D., Duca, F.A., de Wouters, T., Sakar, Y. and Covasa, M. (2011) Up-Regulation of Intestinal Type 1 Taste Receptor 3 and Sodium Glucose Luminal Transporter-1 Expression and Increased Sucrose Intake in Mice Lacking Gut Microbiota. British Journal of Nutrition, 107, 621-630. https://doi.org/10.1017/s0007114511003412 |
| [8] | 王珊珊, 韩永和, 李敏. 饮食和肠道微生物对肥胖的代谢调控作用与机制[J]. 生命的化学, 2021, 41(3): 541-551. |
| [9] | Perry, R.J., Peng, L., Barry, N.A., Cline, G.W., Zhang, D., Cardone, R.L., et al. (2016) Acetate Mediates a Microbiome-Brain-β-Cell Axis to Promote Metabolic Syndrome. Nature, 534, 213-217. https://doi.org/10.1038/nature18309 |
| [10] | Brial, F., Alzaid, F., Sonomura, K., Kamatani, Y., Meneyrol, K., Le Lay, A., et al. (2020) The Natural Metabolite 4-Cresol Improves Glucose Homeostasis and Enhances β-Cell Function. Cell Reports, 30, 2306-2320. https://doi.org/10.1016/j.celrep.2020.01.066 |
| [11] | Hoyles, L., Fernández-Real, J.-M., Federici, M., Serino, M., Abbott, J., Charpentier, J., et al. (2018) Molecular Phenomics and Metagenomics of Hepatic Steatosis in Non-Diabetic Obese Women. Nature Medicine, 24, 1070-1080. https://doi.org/10.1038/s41591-018-0061-3 |
| [12] | de Mello, V.D., Paananen, J., Lindstr？m, J., Lankinen, M.A., Shi, L., Kuusisto, J., et al. (2017) Indolepropionic Acid and Novel Lipid Metabolites Are Associated with a Lower Risk of Type 2 Diabetes in the Finnish Diabetes Prevention Study. Scientific Reports, 7, Article No. 46337. https://doi.org/10.1038/srep46337 |
| [13] | Koh, A., Molinaro, A., St？hlman, M., Khan, M.T., Schmidt, C., Manner？s-Holm, L., et al. (2018) Microbially Produced Imidazole Propionate Impairs Insulin Signaling through mTORC1. Cell, 175, 947-961. https://doi.org/10.1016/j.cell.2018.09.055 |
| [14] | MacDonald, M.J., Fahien, L.A., Mertz, R.J. and Rana, R.S. (1989) Effect of Esters of Succinic Acid and Other Citric Acid Cycle Intermediates on Insulin Release and Inositol Phosphate Formation by Pancreatic Islets. Archives of Biochemistry and Biophysics, 269, 400-406. https://doi.org/10.1016/0003-9861(89)90123-9 |
| [15] | Wang, Z., Chen, Z., Zhang, L., Wang, X., Hao, G., Zhang, Z., et al. (2018) Status of Hypertension in China: Results from the China Hypertension Survey, 2012-2015. Circulation, 137, 2344-2356. https://doi.org/10.1161/circulationaha.117.032380 |
| [16] | GBD 2017 DALYs and HALE Collaborators (2018) Global, Regional, and National Disability-Adjusted Life-Years (DALYs) for 359 Diseases and Injuries and Healthy Life Expectancy (HALE) for 195 Countries and Territories, 1990-2017: A Systematic Analysis for the Global Burden of Disease Study 2017. The Lancet, 392, 1859-1922. https://doi.org/10.1016/S0140-6736(18)32335-3 |
| [17] | 陈冬梅. 空气污染物暴露对高血压大鼠肠道微生物群和心肌组织的影响及机制探讨[D]: [博士学位论文]. 长春: 吉林大学, 2021. |
| [18] | Wang, T., Gao, H., He, C., Gao, L., Wang, B., Hua, R., et al. (2023) Adult Hypertensive Rats Are More Prone to Gut Microflora Perturbation and Fibrosis in Response to Moderate Restraint Stress. Translational Research, 254, 92-114. https://doi.org/10.1016/j.trsl.2022.10.006 |
| [19] | Lu, D., Xu, S., Dai, P., Wu, L., Zhang, H. and Zhou, B. (2022) Gut Microbiota in Hypertensive Patients with versus without Obstructive Sleep Apnea. The Journal of Clinical Hypertension, 24, 1598-1605. https://doi.org/10.1111/jch.14598 |
| [20] | Avery, E.G., Bartolomaeus, H., Rauch, A., Chen, C.-Y., N’Diaye, G., L？ber, U., et al. (2022) Quantifying the Impact of Gut Microbiota on Inflammation and Hypertensive Organ Damage. Cardiovascular Research, 119, 1441-1452. https://doi.org/10.1093/cvr/cvac121 |
| [21] | Romano, K.A., Nemet, I., Prasad Saha, P., Haghikia, A., Li, X.S., Mohan, M.L., et al. (2023) Gut Microbiota-Generated Phenylacetylglutamine and Heart Failure. Circulation: Heart Failure, 16, e009972. https://doi.org/10.1161/circheartfailure.122.009972 |
| [22] | 蔡斌, 张振东, 王宏伟. 肠道微生物及其代谢产物与心力衰竭相关性研究[J]. 贵州医药, 2022, 46(7): 1014-1016. |
